ASCO 2014: Remission of Disseminated Cancer After Using Modified Measles Vaccine
Dr. Angela Dispenzieri on Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy (n.b., using modified measles vaccine)
ABOUT ANGELA DISPENZIERI, MD
Dr. Angela Dispenzieri is a Professor of Medicine and Consultant, Division of Hematology, Department of Internal Medicine at the Mayo Clinic in Rochester, Minnesota. Her main areas of focus include the application of mass spectrometry to the diagnosis and prognosis of patients with plasma cell disorders, immunoglobulin light chain (AL) amyloidosis, POEMS syndrome, and multiple myeloma. View Dr. Angela Dispenzieri’s full biography here.
Previous Post
ASCO 2014: Results of Myeloma XI, a phase III trial comparing different IMiDs
Next Post
ASCO 2014: Prevalence of high symptom burden and its impact on functioning and quality of life in MM